SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905718-21-001585
Filing Date
2021-12-09
Accepted
2021-12-09 21:03:56
Documents
1
Period of Report
2021-12-07

Document Format Files

Seq Description Document Type Size
1 recursion_fm4dec72021.html 4  
1 recursion_fm4dec72021.xml 4 3357
  Complete submission text file 0000905718-21-001585.txt   4850
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Issuer) CIK: 0001601830 (see all company filings)

IRS No.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O LUX CAPITAL MANAGEMENT, LLC 1600 EL CAMINO REAL - SUITE 290 MENLO PARK CA 94025
Business Address
Dar Zavain (Reporting) CIK: 0001852075 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40323 | Film No.: 211483427